203 related articles for article (PubMed ID: 17499915)
1. Identification of arsenic-binding proteins in human breast cancer cells.
Zhang X; Yang F; Shim JY; Kirk KL; Anderson DE; Chen X
Cancer Lett; 2007 Sep; 255(1):95-106. PubMed ID: 17499915
[TBL] [Abstract][Full Text] [Related]
2. Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells.
Zhang T; Lu H; Li W; Hu R; Chen Z
Int J Mol Sci; 2015 Nov; 16(11):26871-9. PubMed ID: 26569224
[TBL] [Abstract][Full Text] [Related]
3. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures.
Hao G; Derakhshan B; Shi L; Campagne F; Gross SS
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1012-7. PubMed ID: 16418269
[TBL] [Abstract][Full Text] [Related]
4. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells.
Li YM; Broome JD
Cancer Res; 1999 Feb; 59(4):776-80. PubMed ID: 10029061
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pyruvate kinase isozyme M2 is mediated by the ubiquitin-specific protease 20.
Kim SR; Kim JO; Lim KH; Yun JH; Han I; Baek KH
Int J Oncol; 2015 May; 46(5):2116-24. PubMed ID: 25708858
[TBL] [Abstract][Full Text] [Related]
7. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
[TBL] [Abstract][Full Text] [Related]
8. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.
Liu CW; Lin YC; Hung CM; Liu BL; Kuo SC; Ho CT; Way TD; Hung CH
Chem Biol Interact; 2018 Jun; 289():98-108. PubMed ID: 29679549
[TBL] [Abstract][Full Text] [Related]
9. Identification of reactive cysteines in a protein using arsenic labeling and collision-induced dissociation tandem mass spectrometry.
Lu M; Wang H; Wang Z; Li XF; Le XC
J Proteome Res; 2008 Aug; 7(8):3080-90. PubMed ID: 18613716
[TBL] [Abstract][Full Text] [Related]
10. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
11. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
[TBL] [Abstract][Full Text] [Related]
12. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R
J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.
Lee J; Kim HK; Han YM; Kim J
Int J Biochem Cell Biol; 2008; 40(5):1043-54. PubMed ID: 18191611
[TBL] [Abstract][Full Text] [Related]
14. Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors.
Lin YF; Tsai WP; Liu HG; Liang PH
Cancer Res; 2009 Sep; 69(17):6879-88. PubMed ID: 19690144
[TBL] [Abstract][Full Text] [Related]
15. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
Yamazaki Y; Kohno K; Yasui H; Kiso Y; Akamatsu M; Nicholson B; Deyanat-Yazdi G; Neuteboom S; Potts B; Lloyd GK; Hayashi Y
Chembiochem; 2008 Dec; 9(18):3074-81. PubMed ID: 19012291
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.
Jiang K; He B; Lai L; Chen Q; Liu Y; Guo Q; Wang Q
Int J Mol Med; 2012 Aug; 30(2):302-8. PubMed ID: 22580449
[TBL] [Abstract][Full Text] [Related]
17. Chemoproteomic Approach for the Quantitative Identification of Arsenic-Binding Proteins.
Dong X; Wang P; Wang Y
Chem Res Toxicol; 2022 Nov; 35(11):2145-2151. PubMed ID: 36269594
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the anticancer potential and tubulin isotype-specific interactions of β-sitosterol.
Pradhan M; Suri C; Choudhary S; Naik PK; Lopus M
J Biomol Struct Dyn; 2018 Jan; 36(1):195-208. PubMed ID: 27960611
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.
Matsui Y; Yasumatsu I; Asahi T; Kitamura T; Kanai K; Ubukata O; Hayasaka H; Takaishi S; Hanzawa H; Katakura S
Bioorg Med Chem; 2017 Jul; 25(13):3540-3546. PubMed ID: 28511909
[TBL] [Abstract][Full Text] [Related]
20. The local electrostatic environment determines cysteine reactivity of tubulin.
Britto PJ; Knipling L; Wolff J
J Biol Chem; 2002 Aug; 277(32):29018-27. PubMed ID: 12023292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
